Trump Pharma Tariff Plan Looks Like Reprieve for Many Drugmakers

President Donald Trump’s plan to impose a 100% tariff on branded and patented drug imports was greeted with a shrug by many investors, who are betting his exemptions for companies with US manufacturing will soften any blow....

Redirecting to full article...